NovaDel’s USPTO Allowance Notice (AMEX:NVD)
Source: http://feedproxy.google.com/~r/FavStocks/~3/_OG8t7PxQB4/Posted on Friday, November 6th, 2009 | In Biotech, Investing Lessons, Stocks to Watch
NovaDel Pharma Inc. (AMEX:NVD) announced that they have received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for claims under U.S. Patent Application No. 10/671,715 entitled “Buccal, Polar and Non-Polar Spray containing Zolpidem” that covers a method of treating insomnia by administering zolpidem to human beings utilizing NovaMist Oral Spray spray technology. NovaDel’s oral spray technology is focused for unmet medical needs for a broad array of existing and future pharmaceutical products. The Company’s most advanced oral spray candidates target angina, nausea, insomnia, migraine headaches and disorders of the central nervous system.
NovaDel Pharma is a leading specialty pharmaceutical company that is into the development of oral spray formulations for a broad range of marketed drugs. The Company offers conventional oral dosage forms that has the potential for faster absorption of drugs into the bloodstream that leads to quick therapeutic effects and reduces first pass liver metabolism that can happen in low doses. Additionally, oral sprays eliminate the use of water or the need to swallow medicines that may prove convenient to the patients. Zolpimist is indicated for the short-term treatment of insomnia characterized by difficulties and problems with sleep initiation.
NovaDel Pharma’s Zolpimist Oral Spray has already been approved by the Food and Drug Administration for the short term treatment of insomnia characterized by difficulties with sleep initiation. This is NovaDel’s second product that has been approved by the FDA that uses NovaDel’s proprietary NovaMist oral spray technology. NovaDel maintains an exclusive worldwide portfolio of intellectual property rights for select compounds using is pioneering oral spray delivery system. Patients who are taking Zolpimist should immediately prepare for bedtime after they take the oral spray and avoid activities like driving or operating dangerous appliances that can cause damage.
Last 5 posts by Jay Garcilazo
- FDA Decision scheduled for Santarus (SNTS) - November 23rd, 2009
- FDA Decision scheduled for Santarus (SNTS) - November 23rd, 2009
- CytRx Technical Breakout on Pending News (NASDAQ:CYTR) - November 23rd, 2009
- CytRx Technical Breakout on Pending News (NASDAQ:CYTR) - November 23rd, 2009
- Will the $20 million payment for VIBATIV pay off? (THRX, JNJ, ALPMF) - November 23rd, 2009
 About Jay Garcilazo (http://favstocks.com)
I grew up in Boca Raton, Florida. After graduating high school I enrolled at Florida State University where I studied Journalism and Political Science. It was around this time that I got a job in the healthcare industry, a job that would give me a lot of experience as I worked and moved up over the next four and a half years. This along with working for a hedge fund manager for years, were the greatest learning experiences of my life so far. I have also been fortunate enough to have lived all over the country in, Austin, Texas, Queens, New York, Great Falls, Montana, Cleveland, Ohio, Chattanooga, Tennessee, Atlanta, Georgia, and all over the state of Florida. As well as living in many places I have traveled all over, been to all of the states except California (Had a layover at LAX once but I don’t think that counts), Oregon, and Hawaii. Traveled most of the Caribbean, I have also been to many destinations in Canada, and Mexico. I even did a stint through Europe. As well as traveling and living all over I have also worked in a great many industries. I have been employed in finance, healthcare, title, mortgage, travel, video game development, hospitality, and news industries. Besides working for an investment company I have also done quite a bit of investing on my own, and through trial and error, learning from mistakes, and watching the news very closely I have made some decent money for myself. |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.